Building the bionic T cell

Drew M. Pardoll

doi:10.1038/nm1207-1411

Building the bionic T cell

Drew M. Pardoll

School of Medicine

Research output: Contribution to journal › Short survey › peer-review

2 Scopus citations

Abstract

Adoptive T cell transfer studies in mice and in cancer patients have shown substantial potential, but also major barriers, for successful therapeutic outcomes. A new strategy may overcome some of these barriers. T cells can now be engineered with 'autocostimulation' properties along with chimeric receptors specific for tumor antigens (pages 1440-1449).

Original language	English (US)
Pages (from-to)	1411-1413
Number of pages	3
Journal	Nature medicine
Volume	13
Issue number	12
DOIs	https://doi.org/10.1038/nm1207-1411
State	Published - Dec 1 2007

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1038/nm1207-1411

Cite this

@article{0e08e5627d2f471aaeb728de3c64700d,

title = "Building the bionic T cell",

abstract = "Adoptive T cell transfer studies in mice and in cancer patients have shown substantial potential, but also major barriers, for successful therapeutic outcomes. A new strategy may overcome some of these barriers. T cells can now be engineered with 'autocostimulation' properties along with chimeric receptors specific for tumor antigens (pages 1440-1449).",

author = "Pardoll, {Drew M.}",

year = "2007",

month = dec,

day = "1",

doi = "10.1038/nm1207-1411",

language = "English (US)",

volume = "13",

pages = "1411--1413",

journal = "Nature medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "12",

}

TY - JOUR

T1 - Building the bionic T cell

AU - Pardoll, Drew M.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Adoptive T cell transfer studies in mice and in cancer patients have shown substantial potential, but also major barriers, for successful therapeutic outcomes. A new strategy may overcome some of these barriers. T cells can now be engineered with 'autocostimulation' properties along with chimeric receptors specific for tumor antigens (pages 1440-1449).

AB - Adoptive T cell transfer studies in mice and in cancer patients have shown substantial potential, but also major barriers, for successful therapeutic outcomes. A new strategy may overcome some of these barriers. T cells can now be engineered with 'autocostimulation' properties along with chimeric receptors specific for tumor antigens (pages 1440-1449).

UR - http://www.scopus.com/inward/record.url?scp=36849091563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849091563&partnerID=8YFLogxK

U2 - 10.1038/nm1207-1411

DO - 10.1038/nm1207-1411

M3 - Short survey

C2 - 18064030

AN - SCOPUS:36849091563

SN - 1078-8956

VL - 13

SP - 1411

EP - 1413

JO - Nature medicine

JF - Nature medicine

IS - 12

ER -

Building the bionic T cell

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this